Trial intelligence / Profile preview

Topical Tacrolimus (Protopic) in Cutaneous Lupus Erythematosus

2004-005020-41Phase 2Completed

Sponsor
Heinrich Heine University Düsseldorf
Start
Dec 2004
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of Envarsus XR in cutaneous lupus erythematosus (CLE), sponsored by Heinrich Heine University Düsseldorf. Started Dec 2004; status: completed.

02

Drugs

Envarsus XR
03

Conditions

cutaneous lupus erythematosus (CLE)

Beyond the preview

Go deeper on 2004-005020-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-005020-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call